Mannkind (MNKD) EBIT (QoQ) (2010 - 2026)
Mannkind (MNKD) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Mannkind |
1.13 Bn |
995.19 Mn |
82.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
78.31% |
| Dec 31, 2025 |
-140.68% |
| Sep 30, 2025 |
256.60% |
| Jun 30, 2025 |
-76.23% |
| Mar 31, 2025 |
-15.86% |
| Dec 31, 2024 |
107.64% |
| Sep 30, 2024 |
-23.18% |
| Jun 30, 2024 |
-0.67% |
| Mar 31, 2024 |
112.80% |
| Dec 31, 2023 |
54.17% |
| Sep 30, 2023 |
196.17% |
| Jun 30, 2023 |
128.69% |
| Mar 31, 2023 |
53.10% |
| Dec 31, 2022 |
-33.09% |
| Sep 30, 2022 |
53.02% |
| Jun 30, 2022 |
3.77% |
| Mar 31, 2022 |
11.32% |
| Dec 31, 2021 |
-263.70% |
| Sep 30, 2021 |
35.85% |
| Jun 30, 2021 |
-65.93% |
